Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 57-68

  Büssing, Arndt ^a   Multani, Asha S ^b   Pathak, Sen ^b   Pfüller, Uwe ^c   Schietzel, M ^d  

^a Krebsforschung Herdecke   (Germany)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d Krebsforschung Herdecke   (Germany)

Author keywords

Apoptosis; Bcl 2; CD8+ T lymphocytes; Chromosomal affections; Mistletoe lectins; p53; Protein synthesis inhibition; Sister chromatid exchanges

Indexed keywords

LIPOCORTIN 5; MEMBRANE PROTEIN; MOMORDIN; N ACETYLGALACTOSAMINE; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN P53; VISCUM ALBUM LECTIN; VOLKENSIN;

ANAPHASE; APOPTOSIS; ARTICLE; CELL MEMBRANE; CYTOTOXICITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS; SISTER CHROMATID EXCHANGE; T LYMPHOCYTE; TELOMERE; TUMOR CELL LINE;

APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; GLYCOPROTEINS; HIV INFECTIONS; HUMANS; LECTINS; MONOCYTES; N-GLYCOSYL HYDROLASES; NEOPLASM PROTEINS; PLANT LECTINS; PLANT PREPARATIONS; PLANT PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SISTER CHROMATID EXCHANGE; TOXINS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

SIGANUS; VISCUM ALBUM;

EID: 0032516664     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00124-4     Document Type: Article

References (55)

1. Bazar L.S., Deeg J. Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and Jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp. Hematol. 20:1992;80-86.
2. Beverley P.C.L. Generation of T-cell memory. Curr. Opin. Immunol. 8:1996;327-330.
3. Büssing A., Azhari A., Ostendorp H., Lehnert A., Schweizer K. Viscum album L. extracts reduce sister chromatid exchanges in cultured peripheral blood mononuclear cells. Eur. J. Cancer. 30A:1994;1836-1841.
4. Büssing A., Regnery A., Schweizer K. Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: sister chromatid exchanges and activation/proliferation marker expression. Cancer Lett. 94:1995;199-205.
5. Büssing A., Jungmann H., Suzart K., Schweizer K. Suppression of sister chromatid exchange-inducing DNA lesions in cultured peripheral blood mononuclear cells by Viscum album L. J. Exp. Clin. Cancer Res. 15:1996;107-114.
6. Büssing A., Suzart K., Bergmann J., Pfüller U., Schietzel M., Schweizer K. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett. 99:1996;59-72.
7. Büssing A. Induction of apoptosis by the mistletoe lectins. A review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis. 1:1996;25-32.
8. Büssing A., Suzart K., Schweizer K. To live and let die - differences in the apoptosis-inducing properties of Viscum album L. extracts. Anticancer Drugs. 8(Suppl. 1):1997;S9-S14.
9. lo) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L., Cell Death Diff. 5 (1998) 231-240.
10. Canman C.E., Gilmer T.M., Coutts S.B., Kastan M.B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600-611.
11. Deen D.F., Morgan W.F., Tofilon P.J., Barcellos-Hoff M.H. Measurement of sister chromatid exchanges and their relationship to DNA damage, repair and cell killing. Pharmacol. Ther. 42:1989;349-360.
12. Dietrich J.B., Ribéreau-Gayon G., Jung M.L., Franz H., Beck J.P., Anton R. Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single chain ribosome-inhibiting proteins. Anticancer Drugs. 3:1992;507-511.
13. Doser C., Doser M., Hülsen H., Mechelke F. Influence of carbohydrates on the cytotoxicity of an aqueous mistletoe drug and of purified lectins tested on human T-leukemia cells. Arzneim Forsch/Drug Res. 39:1989;647-651.
14. R. Eifler, K. Pfüller, W. Göckeritz, U. Pfüller, Improved procedures for isolation and standardization of mistletoe lectins and their subunits: lectin pattern of the European mistletoe, in: J. Basu, M. Kundu, P. Chakrabarti (Eds.), Lectins: Biology, Biochemistry, Clinical Biochemistry, Vol. 9, Wiley Eastern, New Delhi, 1993, pp. 144-151.
15. Effros R.B., Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol. Today. 18:1997;450-454.
16. Evan G.I., Brown L., Whyte M., Harrington E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 123:1995;7-22.
17. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumour suppressor protein p53 by DNA damaging agents. Oncogene. 8:1993;307-318.
18. Green D.R., Martin S.J. The killer and the executioner: how apoptosis controls malignancy. Curr. Opin. Immunol. 7:1995;694-703.
19. Healy K.C. Telomere dynamics and telomerase activation in tumour progression: prospects for prognosis and therapy. Oncol. Res. 7:1995;121-130.
20. K. Hostanska, T. Hajto, K. Weber, J. Fischer, H. Lentzen, B. Sütterlin, R. Saller, A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes, Nat. Immunol. 15 (1996-97) 295-311.
21. Hülsen H., Mechelke F. The influence of a mistletoe preparation on suspension cell cultures of human leukemia and human myeloma cells. Arzneim Forsch/Drug Res. 32:1982;1126-1127.
22. Janssen O., Scheffler A., Kabelitz D. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumour cells due to the induction of programmed cell death (apoptosis). Arzneim Forsch/Drug Res. 43:1993;1221-1227.
23. Kochi S.K., Collier R.J. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp. Cell Res. 208:1993;296-302.
24. Koester S.K., Roth P., Mikulka W.R., Schlossmann S.F., Zhang C., Bolton W.E. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry. 29:1977;306-312.
25. Koopman G., Reutelingsperger C.P.M., Kuijten G.A.M., Keehnen R.M.J., Pals S.T., van Oers M.H.J. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 85:1994;532-540.
26. Kuirbitz S.J., Plunkett B.S., Walsh W.V., Kasten M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
27. Martin S.J. Apoptosis: suicide, execution or murder? Trends Cell Biol. 3:1993;141-144.
28. Martin S.J. Protein or RNA synthesis inhibition induces apoptosis of mature human CD4+ T cell blasts. Immunol. Lett. 35:1993;125-134.
29. Memon S.A., Moreno M.B., Petrak D., Zacharchuk C.M. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:1995;4644-4652.
30. Mercer W.E., Baserga R. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes. Exp. Cell Res. 160:1985;31-46.
31. Metzner G., Franz H., Kindt A., Schuman I., Fahlbusch B. Effects of lectin I from mistletoe (ML I) and its isolated A and B chains on human mononuclear cells: mitogenic activity and lymphokine release. Pharmazie. 42:1987;337-340.
32. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffmann B., Reed J.C. Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
33. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
34. Mobley J.L., Rigby S.M., Dailey M.O. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens. J. Immunol. 153:1994;5443-5452.
35. Monteiro J., Batliwalla F., Ostrer H., Gregersen P.K. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156:1996;3587-3590.
36. Moreno M.B., Memon S.A., Zacharchuk C.M. Apoptosis signaling pathways in normal T cells. Differential activity of Bcl-2 and IL-1β-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. J. Immunol. 157:1996;3845-3849.
37. Mountz J.D., Zhou T., Wu J., Wang W., Su X., Cheng J. Regulation of apoptosis in immune cells. J. Clin. Immunol. 15:1995;1-16.
38. Multani A.S., Hopwood V.L., Pathak S. A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res. 16:1996;3435-3438.
39. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
40. Pathak S., Dave B.J., Gagos S.H. Chromosome alterations in cancer development and apoptosis. In Vivo. 8:1994;843-850.
41. Pathak S., Risin S., Brown N.M., Berry K.K. Telomeric association of chromosomes is an early manifestation of programmed cell death. Int. J. Oncol. 4:1994;323-328.
42. Pathak S., Multani A.S., Amoss M.S. Jr. Telomere, telomerase and malignant melanomas in human and domestic mammals. Archivos Zootechnia. 45:1996;141-149.
43. Perry P., Evans H.J. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature. 258:1975;121-125.
44. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1.
45. Reed J.C., Miyashita T., Takayama S., Wang H.G., Sato T., Krajewski S., Aimé-Sempé C., Bodrug S., Kitada S., Hanada M. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60:1996;23-32.
46. Ribéreau-Gayon G., Jung M.L., Baudino S., Sallé G., Beck J.P. Effects of mistletoe (Viscum album L.) extracts on cultured tumour cells. Experientia. 42:1986;594-599.
47. Roederer M., Dubs J.G., Anderson M.T., Raju P.A., Herzenberg L.A., Herzenberg L.A. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:1995;2061-2066.
48. Sharma H.W., Maltese J.Y., Zhu X., Kaiser H.E., Narayanan R. Telomeres, telomerase and cancer: is the magic bullet real? Anticancer Res. 16:1996;511-515.
49. Stirpe F., Sandvig K., Olsnes S., Pihl A. Action of Viscumin, a toxic lectin from mistletoe, on cells in culture. J. Biol. Chem. 257:1982;13271-13277.
50. Tereda N., Lucas J.J., Gelfand E.W. Differential regulation of the tumour suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol. 147:1991;698-704.
51. Tucker J.D., Auletta A., Cimino M.C., Dearfield K.L., Jacobson-Kram D., Rice R.R., Carrano A.V. Sister chromatid exchange: second report of the Gene-Tox program. Mutat. Res. 297:1993;101-180.
52. Urech K., Schaller G., Ziska P., Giannattasio M. Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumour cells in culture. Phytother. Res. 9:1995;49-55.
53. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184:1995;39-51.
54. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
55. Zhang C., Ao Z., Seth A., Schlossmann S.F. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J. Immunol. 157:1996;3980-3987.